Calculated PRA (CPRA): The new measure of sensitization for transplant candidates: Special feature

American Journal of Transplantation

Volumn 10, Issue 1, 2010, Pages 26-29

  Cecka, J M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Access to transplantation; Anti HLA antibodies; Crossmatching; Donor specific antibodies; Histocompatibility; PRA

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN; PANEL REACTIVE ANTIBODY;

ALLELE; ARTICLE; GRAFT RECIPIENT; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOASSAY; KIDNEY; MEASUREMENT; ORGAN DONOR; PRIORITY JOURNAL; RISK; SENSITIZATION; UNITED STATES;

HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY; UNITED STATES; WAITING LISTS;

EID: 72549094020     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02927.x     Document Type: Article

References (20)

1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969 280 : 735 739.
2. Pei R, Lee JH, Chen T, Rojo S, Terasaki PI. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Human Immunology 1999 60 : 1293 1302.
3. Zachary AA, Montgomery RA, Ratner LE et al. Specific and durable elimination of antibody to donor HLA antigens in renal transplant patients. Transplantation 2003 76 : 1519 1525.
4. Vo AA, Lukovsky M, Toyoda M et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008 359 : 242 251.
5. Gloor J, Cosio F, Lager DJ, Stegall MD. The spectrum of antibody-mediated renal allograft injury: Implications for treatment. Am J Transplant 2008 8 : 1367 1373.
6. Bray RA, Nolen JD, Larsen C et al. Transplanting the highly sensitized patient: The Emory Algorithm. Am J Transplant 2006 6 : 2307 2315.
7. Tambur AR, Leventhal J, Kaufman DB et al. Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: The Northwestern University experience. Transplantation 2008 86 : 1052 1059.
8. Bingaman AW, Murphey CL, Palma-Vargas J, Wright F. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 2008 86 : 1864 1868.
9. Vaidya S. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches. Transplantation 2008 85 : 1046 1050.
10. Zachary AA, Montgomery RA, Leffell MS. Defining unacceptable HLA antigens. Curr Opin Organ Transplant 2008 13 : 405 410.
11. Nikaein A, Cherikh W, Nelson K et al. Organ procurement and transplantation network/united network for organsharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients. Transplantation 2009 87 : 557 562.
12. Tambur AR, Ramon DS, Kaufman DB. Perception versus reality?: Virtual crossmatch - How to overcome some of the technical and logistic limitations. Am J Transplant 2009 9 : 1886 1893.
13. Reinsmoen NL, Lai CH, Vo A et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 2008 86 : 820 825.
14. Zachary AA, Sholander JT, Houp JA, Leffell MS. Using real data for a virtual crossmatch. Human Immunol 2009 70 : 574 579.
15. Phelan D, Mohanakumar T, Ramachandran S, Jendrisak MD. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay. Human Immunol 2009 70 : 584 588.
16. Aubert V, Venetz JP, Pantaleo G, Pascual M. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Human Immunol 2009 70 : 580 583.
17. Ho EK, Vasilescu ER, Colovai AI et al. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. Transplant Immunol 2008 20 : 61 67.
18. Tait BD, Hudson F, Cantwell L et al. Luminex technology for HLA antibody detection in solid organ transplantation (Review). Nephrology 2009 14 : 247 254.
19. Vaidya S, Hilson B, Sheldon S, Cano P, Fernandez-Vina M. DP-reactive antibody in a zero mismatch renal transplant pair. Hum Immunol 2007 68 : 947 949.
20. Goral S, Prak EL, Kearns J, Bloom RD et al. Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation. Nephrol Dial Transplant 2008 23 : 390 392.